MT-303(Microbiome)

N/A

Report date: 2024/07/05 11:08:39
NME

Base Information

Drug NameMT-303(Microbiome)
Drug Alias NameMT-303(Microbiome)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFatty acids inhibitorsLipid inhibitorsMicrobiome modulators
TargetsFatty acidsLipid
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMicrobiome Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMicrobiome Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A